HMH Spin-out Company Gets $1 Million Investment   

HMH Spin-out Company Gets $1 Million Investment

What You Need To Know

Breakthrough in detection of novel biomarkers

The selection of circulating EVs for disease detection has been elusive to medicine thus far, but technological advances in their isolation and analysis of molecular cargos are enabling the detection of novel biomarkers. 

Diagnostic assays derived from this technology will help monitor disease biomarkers for earlier-than-ever detection of tumors and a wide range of other diseases.

We use cookies to improve your site experience. By using this site,
you agree to our Terms & Conditions. Also, please read our Privacy Policy. Accept All CookiesLearn More